Michelle Hang
Acute Care · New York, NYNPI 1336679752
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 25.8% of the total. Among acute care clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $36.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$902
- Johnson & Johnson$764
- Amgen$394
- Abbott$299
- E.r. Squibb & Sons, L.L.C.$297
- Shockwave Medical, Inc$166
- plus $678 from 13 others
What the payments were for
- Food & beverage$3,500100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $902 |
| Johnson & Johnson | 18 | $764 |
| Amgen | 14 | $394 |
| Abbott | 7 | $299 |
| E.r. Squibb & Sons, L.L.C. | 15 | $297 |
| Shockwave Medical, Inc | 2 | $166 |
| Boston Scientific | 2 | $148 |
| Terumo Medical Corporation | 1 | $123 |
| Surmodics, Inc. | 8 | $90 |
| Pfizer | 3 | $61 |
| Cardiva Medical, Inc. | 3 | $56 |
| Chiesi USA, Inc. | 2 | $38 |
| Bayer | 1 | $34 |
| Boehringer Ingelheim | 1 | $29 |
| Medtronic | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Abiomed | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Novartis | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,500 in reported general payments places this provider in the 90th percentile of 980 acute care providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 47 | $510 |
| Atorvastatin Calcium | 13 | $235 |
| Amlodipine Besylate | 11 | $126 |
| Rosuvastatin Calcium | 16 | $106 |
Paid to pharmacies, not to this prescriber.
Other acute care in New York
- Daniel VerinaNew York$464K
- Katie WorthingtonNew York$25K
- Loveth AdenugaNew York$20K
- Katherine DukeNew York$18K
- Julie Anne RoldanNew York$10K
- Lauren Dela CruzNew York$9K
- Kristen DonchezNew York$8K
- Tracy Valerie BertizNew York$7K
- Jennifer UllmanNew York$7K
- Sara-Jane DakroubNew York$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.